Japan · Delayed Price · Currency is JPY Xebio Holdings Statistics
Total Valuation
Xebio Holdings has a market cap or net worth of JPY 43.00 billion. The enterprise value is 33.63 billion.
| Market Cap | 43.00B |
| Enterprise Value | 33.63B |
Important Dates
The next confirmed earnings date is Saturday, August 8, 2026.
| Earnings Date | Aug 8, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Xebio Holdings has 41.38 million shares outstanding. The number of shares has decreased by -4.30% in one year.
| Current Share Class | 41.38M |
| Shares Outstanding | 41.38M |
| Shares Change (YoY) | -4.30% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 8.38% |
| Owned by Institutions (%) | 13.79% |
| Float | 20.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | 18.50 |
| P/OCF Ratio | 4.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.60, with an EV/FCF ratio of 14.47.
| EV / Earnings | -15.54 |
| EV / Sales | 0.13 |
| EV / EBITDA | 3.60 |
| EV / EBIT | 14.18 |
| EV / FCF | 14.47 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.83 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | 2.70 |
| Interest Coverage | 23.02 |
Financial Efficiency
Return on equity (ROE) is -2.02% and return on invested capital (ROIC) is 2.14%.
| Return on Equity (ROE) | -2.02% |
| Return on Assets (ROA) | 0.72% |
| Return on Invested Capital (ROIC) | 2.14% |
| Return on Capital Employed (ROCE) | 1.78% |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | 101.54M |
| Profits Per Employee | -870,825 |
| Employee Count | 2,485 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, Xebio Holdings has paid 106.00 million in taxes.
| Income Tax | 106.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.87% in the last 52 weeks. The beta is 0.27, so Xebio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -11.87% |
| 50-Day Moving Average | 1,013.20 |
| 200-Day Moving Average | 1,079.80 |
| Relative Strength Index (RSI) | 58.76 |
| Average Volume (20 Days) | 155,210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Xebio Holdings had revenue of JPY 252.33 billion and -2.16 billion in losses. Loss per share was -52.27.
| Revenue | 252.33B |
| Gross Profit | 95.09B |
| Operating Income | 2.37B |
| Pretax Income | -2.32B |
| Net Income | -2.16B |
| EBITDA | 9.34B |
| EBIT | 2.37B |
| Loss Per Share | -52.27 |
Balance Sheet
The company has 15.81 billion in cash and 6.29 billion in debt, with a net cash position of 9.52 billion or 230.10 per share.
| Cash & Cash Equivalents | 15.81B |
| Total Debt | 6.29B |
| Net Cash | 9.52B |
| Net Cash Per Share | 230.10 |
| Equity (Book Value) | 118.31B |
| Book Value Per Share | 2,855.18 |
| Working Capital | 60.41B |
Cash Flow
In the last 12 months, operating cash flow was 9.68 billion and capital expenditures -7.36 billion, giving a free cash flow of 2.32 billion.
| Operating Cash Flow | 9.68B |
| Capital Expenditures | -7.36B |
| Depreciation & Amortization | 6.97B |
| Net Borrowing | -564.00M |
| Free Cash Flow | 2.32B |
| FCF Per Share | 56.16 |
Margins
Gross margin is 37.69%, with operating and profit margins of 0.94% and -0.86%.
| Gross Margin | 37.69% |
| Operating Margin | 0.94% |
| Pretax Margin | -0.92% |
| Profit Margin | -0.86% |
| EBITDA Margin | 3.70% |
| EBIT Margin | 0.94% |
| FCF Margin | 0.92% |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 3.35%.
| Dividend Per Share | 35.00 |
| Dividend Yield | 3.35% |
| Dividend Growth (YoY) | 7.69% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 4.30% |
| Shareholder Yield | 7.62% |
| Earnings Yield | -5.03% |
| FCF Yield | 5.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 28, 2006. It was a forward split with a ratio of 1.5.
| Last Split Date | Mar 28, 2006 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Xebio Holdings has an Altman Z-Score of 2.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.57 |
| Piotroski F-Score | 5 |